Nyu Langone Health
Clinical trials sponsored by Nyu Langone Health, explained in plain language.
-
Liver cancer combo trial halted early – what it means
Disease control TerminatedThis phase II trial tested whether adding either BMS-986253 or cabiralizumab to the immunotherapy drug nivolumab could shrink tumors better than nivolumab alone in people with advanced liver cancer. Only 13 participants were enrolled before the study was terminated. The goal was …
Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Saline mist and chest taps: could this combo help sick babies breathe easier?
Symptom relief TerminatedThis study looked at whether giving infants with bronchiolitis a saltwater mist plus gentle chest tapping every 6 hours helps them get better faster. The trial included 75 babies under 2 years old who were in the hospital and needed extra oxygen. Unfortunately, the study was stop…
Phase: PHASE4 • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Tiny implant zaps nerves to boost stroke rehab
Knowledge-focused TerminatedThis study tested whether a small implanted device that stimulates the vagus nerve could improve arm and hand function in people who had a stroke at least a year ago. Four participants received either real or sham stimulation paired with physical therapy. The goal was to see how …
Phase: NA • Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC